Exploring Which of the Following Medications is Able to Cross the Blood-Brain Barrier to Effectively Treat Central Nervous System Tumors?
•
3 min read
The blood-brain barrier (BBB) effectively blocks nearly all large-molecule drugs and up to 98% of small-molecule drugs from reaching the central nervous system (CNS), posing a formidable challenge in treating brain tumors. Overcoming this barrier is critical for identifying which of the following medications is able to cross the blood-brain barrier to effectively treat central nervous system tumors, a quest driving modern oncology and pharmacology research.
